You are here » Home » Companies » Company Overview » Unjha Formulations Ltd

Unjha Formulations Ltd.

BSE: 531762 Sector: Health care
NSE: N.A. ISIN Code: INE576D01015
BSE 15:10 | 16 Feb 12.20 -0.35
(-2.79%)
OPEN

13.15

HIGH

13.17

LOW

12.15

NSE 05:30 | 01 Jan Stock Is Not Traded.
OPEN 13.15
PREVIOUS CLOSE 12.55
VOLUME 4000
52-Week high 25.00
52-Week low 10.11
P/E 29.76
Mkt Cap.(Rs cr) 5
Buy Price 12.15
Buy Qty 200.00
Sell Price 12.55
Sell Qty 2000.00
OPEN 13.15
CLOSE 12.55
VOLUME 4000
52-Week high 25.00
52-Week low 10.11
P/E 29.76
Mkt Cap.(Rs cr) 5
Buy Price 12.15
Buy Qty 200.00
Sell Price 12.55
Sell Qty 2000.00

Unjha Formulations Ltd. (UNJHAFORMUL) - Company History

Unjha Formulations was established in Jun.'87 as a partnership firm for manufacturing pharmaceutical formulations in the Mehsana district of Gujarat. It was promoted by Shambhubhai A Patel. The company manufactures pharmaceutical formulations like liquids, powder, tablets, capsules, injectibles, etc. It is one of the largest manufacturers of isabgul products in India. The company's products are classified under two divisions -- human consumption and veterinary products. Company launched four new products viz.Bericof, Protobal-NT, Formentin Tablets and Nalizole in the year 1997-98. The Company commenced its commercial production and was successfully expanding its customer base throughout the Country including U.P. Territory. Company also interested on development of Export Markets for Ferrous Sulphate, Albendazole Bolus and Iron Folic Tablets to supplement the present law domestic demand situation and achieved export turnover of Rs.0.98 during the year 1997-98. The Company has made manufacturing agreement with Nicholas Piramal India Limited, Mumbai for sale of Isabgol Husk based Product "FYBOGEL".The company received a confirm export order worth Rs.30.00 lacs.